Strategic Growth KORU Medical is a publicly traded medical devices company with a revenue range of 25M-50M and a focus on home and specialty infusion solutions. This presents opportunities for channel partnerships, distribution agreements, and hospital or clinic procurement programs to scale market reach.

Clinical Validation Recent engagement at professional congresses and focus on presenting real-world data for FreedomEDGE in infusion clinics indicates a strong emphasis on clinical credibility. Leverage opportunities to co-market case studies, white papers, and clinician-led webinars to drive adoption among infusion centers and oncology clinics.

Expansion & Collaboration Active hiring of senior leadership and upcoming joint platform infusion system project with SCHOTT Pharma suggest an openness to strategic collaborations. Target coordinated sales pitches around platform integration, compatible accessories, and bundled solutions for healthcare systems seeking end-to-end infusion hardware.

Product Portfolio Core offerings include FREEDOM60 and FreedomEdge syringe infusion systems, precision flow rate tubing, and high-flow subcutaneous safety needles. Opportunities exist to upsell integrated tubing and needle sets, consumables, and service/support contracts to existing customers.

Market & Access Presence in home infusion space with a focus on patient experience aligns with trends toward home-based care and value-based procurement. Engage with DSO networks, ambulatory infusion centers, and payer-recommended pathways to position KORU as a preferred supplier for scalable home infusion solutions.